Ausgabe 5/2021
Inhalt (12 Artikel)
Open Access
Current Opinion
MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
Christine Hum, Julia Loiselle, Nadine Ahmed, Tyler A. Shaw, Caroline Toudic, John Paul Pezacki
Leading Article
Pain Management in Chronic Pancreatitis: Summary of Clinical Practice, Current Challenges and Potential Contribution of the M-ANNHEIM Classification
Alexander Schneider, Michael Hirth
Leading Article
Targeted Therapy Approaches for MET Abnormalities in Non-Small Cell Lung Cancer
Edward B. Garon, Paige Brodrick
Review Article
Post-Dialysis Parenteral Antimicrobial Therapy in Patients Receiving Intermittent High-Flux Hemodialysis
Christo Cimino, Yvonne Burnett, Nikunj Vyas, Anne H. Norris
Open Access
Adis Drug Evaluation
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
Yvette N. Lamb
Open Access
Adis Drug Evaluation
Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
Yahiya Y. Syed
Open Access
Letter to the Editor
Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
Udo Bonnet, Heath McAnally, Norbert Scherbaum
Letter to the Editor
Authors’ Reply to Bonnet et al. “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
Kirk E. Evoy, Sarvnaz Sadrameli, Jillian Contreras, Jordan R. Covvey, Alyssa M. Peckham